The Phase 2 Examination includes written papers and viva voce components to assess candidates’ knowledge of radiation therapy, clinical oncology and pathology and their ability to analyse, interpret and apply this, and intrinsic role competencies, to the assessment and management of patients with cancer. The Eligibility and Readiness to Sit Phase 2 Examination Policy can be found here.
To be eligible to apply for the Phase 2 Examination from 2023, trainees must be in Phase 2 of training, be a financial, radiation oncology, student member of the RANZCR, be in an accredited radiation oncology training position and have completed:
All trainees must have rotated to another training site, other than their home training site, for a minimum of 12 months FTE (in total) prior to sitting the Phase 2 Examination.
The Phase 2 Examination is divided into two domains:
Each domain area consist of two components written papers and viva voce (oral) examination.
A successful pass in the Phase 2 Examination requires the candidate to pass both components and domains.
Written Papers
Three written papers, aligned to the Radiation Oncology Learning Outcomes, including:
Viva Voce Examination
The viva voce examination for Radiation Therapy and Clinical Oncology domains includes:
Planning viva
The planning component is designed to assess the candidate’s knowledge of treatment planning equipment. It also assesses their ability to evaluate treatment planning information and to justify the reasons for selecting the most appropriate treatment plan for an individual case.
Clinical cases
The clinical cases are designed to assess the candidate’s ability to:
Clinical cases will require the candidate to demonstrate knowledge and skills in relation to:
Written Paper
The Pathology written paper which is aligned to the Radiation Oncology Learning Outcomes, comprises of 6 short answer/short essay questions to be completed in 3 hours.
The viva voce examination for Pathology consists of 6 questions of 5 minutes each (with clinical prompts and specimen images).
The Pathology viva is designed to assess the candidate’s knowledge of clinical Pathology as it relates to the practice of Radiation Oncology.
The Pathology viva is designed to assess a range of competencies including the ability to:
Candidates are asked a series of questions in relation to the prompt (e.g. a photograph of a pathology specimen). These might be related to the case in question specifically, or to the condition more generally. These may also include presentation of further case related material or scenario-based questions.
Demonstration Digital Examination Site
The RANZCR Radiation Oncology Phase 2 Written Examinations are now being delivered on a new digital platform.
A demonstration digital examination site has been developed. The demonstration digital examination site replicates the real examination with its use of tools and question navigation capabilities used on the digital platform.
Candidates are encouraged to familiarise themselves with the new digital platform before attempting the examination.
The demonstration digital examination site consists of:
Questions in each of the Phase 2 Examination domains:
The demonstration digital examination site is not intended to be a study tool, but instead a method for candidates to familiarise themselves with the new digital platform.
The digital platform will include a countdown timer for the RANZCR examinations so that candidates know how much time remains during the live exam. This has intentionally been disabled for the demonstration digital examination site so that candidates can spend as much time as they desire in the demonstration site.
Candidates can access the demonstration digital examination site through the links and logins below.
Demonstration Digital Examination
Login ID: 11007
Password: 11007
The demonstration digital examination site requires PINs to access the different examinations available:
Radiation Oncology Phase 2 Examination Demo PIN: 430694
Please note the platform works best on the Google Chrome browser.
Radiation Oncology Digital Examinations Frequently Asked Questions (FAQs)
This document provides answers to frequently asked questions in relation to the changes to the examinations and the digital platform.
In order to pass the Phase 2 Examination overall, a candidate must pass both subject areas:
A candidate must sit for both subject areas of the examination on their first attempt.
In order to pass Radiation Therapy and Clinical Oncology subject area overall, the candidate must pass the written examination and the viva voce examination in Radiation Therapy and Clinical Oncology in the same series.
In order to pass Pathology subject area overall, the candidate must pass the written examination and the viva voce examination in Pathology in the same series.
If a candidate sits for both subject areas in an Examination series, but fails one subject area, they may carry the pass as a credit to the subsequent Examination series. They will only need to attempt the subject area they failed. If they fail the subject area for a second time, they will need to re-sit both subject areas at their next attempt to obtain a pass overall.
A credit for a subject area, only applies the examination series immediately following.
A candidate may attempt the Phase 2 Examination up to a maximum of 3 times, regardless of whether the candidate sits one or both subject areas.
2022- Series 2
2022 – Series 1
2021
2020 – Series 2
2020 – Series 1
2019 – Series 2
2019 – Series 1
2018 – Series 2
2018 – Series 1
2017 – Series 2
2017 – Series 1
2016 – Series 2
2016 – Series 1
2015 – Series 2
2015 – Series 1
2014 – Series 2
2014 – Series 1
2013 – Series 2
2013 – Series 1
2012
2011
2010
1999 to 2009 (Radiation Therapy)
1999 to 2009 (Clinical Oncology)
1999 to 2009 (Tumour Pathology)
Please note, the Phase 2 Examination Course is not a mandatory training requirement.
The Phase 2 Examination Course is conducted by presenters and facilitators including College Phase 2 examiners.
The aims of the Phase 2 Examination Course are to provide:
Kay Scott Prize
The Kaye Scott Prize is awarded to a candidate whose performance is regarded as outstanding in the Phase 2 Examination.
This prize is named in honour of the late Dr Kaye Scott, who played a vital role in the life of our College for many years in roles such as President, Warden of the Membership and Chair of various Education Committees.
The winner receives a cash prize equivalent to the cost of their examination fee and complimentary early bird registration for the RANZCR Annual Scientific Meeting for the following year for presentation of their prize.
The prize is awarded to a trainee who is on their first attempt.
For more information, and terms and conditions, refer to the Examination Prizes on the College website.